SCHEMBL5109860

SCHEMBL5109860

CN(C(=O)OC(C)(C)C)c1ncnc2c1ncn2-c1ccc(NC(=O)Nc2ccc(CCO)c(C(F)(F)F)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTK2B Q14289 2/20 0.39
▸ PTK2 Q05397 1/20 0.39
▸ TRPV1 Q8NER1 3/20 0.39
▸ DDX3X O00571 2/20 0.38
▸ KDR P35968 7/20 0.36
▸ BRAF P15056 4/20 0.36
▸ SRC P12931 3/20 0.36
▸ RET P07949 3/20 0.36
▸ RAF1 P04049 2/20 0.36
▸ FGFR3 P22607 2/20 0.36
▸ AURKA O14965 2/20 0.36
▸ AURKB Q96GD4 2/20 0.36
▸ MAPK14 Q16539 2/20 0.36
▸ TNNI3K Q59H18 2/20 0.36
▸ ABL1 P00519 2/20 0.36
▸ CDK2 P24941 2/20 0.36
▸ CDK8 P49336 2/20 0.36
▸ STK25 O00506 1/20 0.36
▸ CIT O14578 1/20 0.36
▸ MAP2K7 O14733 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5105278 0.95 PTK2B (0.41) PTK2BPTK2TRPV1DDX3XKDR
SCHEMBL5110943 0.90 PTK2B (0.39) PTK2BPTK2KDRBRAFSRC
SCHEMBL5106909 0.88 RAF1 (0.44) PTK2BPTK2KDRBRAFRAF1
SCHEMBL5118992 0.87 PTK2 (0.39) PTK2BPTK2DDX3XKDRBRAF
SCHEMBL5105956 0.86 PTK2 (0.40) PTK2BPTK2KDRBRAFRAF1
SCHEMBL5108237 0.86 PTK2 (0.40) PTK2BPTK2DDX3XKDRBRAF
SCHEMBL5119150 0.86 PTK2 (0.40) PTK2BPTK2KDRBRAFRAF1
SCHEMBL5112032 0.84 KDR (0.45) PTK2BPTK2KDRBRAFSRC
SCHEMBL5110253 0.81 PTK2 (0.42) PTK2BPTK2KDRBRAFFGFR3
SCHEMBL5110968 0.81 KDR (0.49) PTK2BPTK2KDRBRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8609656-B2 Heteroarylphenylurea derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2013-12-17 — — US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
US-20080119466-A1 Heteroarylphenylurea Derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
EP-1724258-A1 HETEROARYLPHENYLUREA DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-11-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119466-A1 Heteroarylphenylurea Derivative CHRM1, CBR3, CHRM2 PTK2B 2304/4885PTK2 3377/4885TRPV1 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback